Pregled bibliografske jedinice broj: 1146381
Immunity and cancer: role of tumor – infiltrating lymphocytes in triple negative breast cancer
Immunity and cancer: role of tumor – infiltrating lymphocytes in triple negative breast cancer // Libri oncologici : Croatian journal of oncology, 49 (2021), 1; 20-28 doi:10.20471/LO.2021.49.01.03 (recenziran, pregledni rad, stručni)
CROSBI ID: 1146381 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Immunity and cancer: role of tumor –
infiltrating lymphocytes in triple negative
breast cancer
Autori
Tečić Vuger, Ana ; Šeparović, Robert ; Vazdar, Ljubica ; Pavlović, Mirjana ; Linarić, Petra ; Šitić, Sanda ; Vrbanec, Damir
Izvornik
Libri oncologici : Croatian journal of oncology (0300-8142) 49
(2021), 1;
20-28
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, stručni
Ključne riječi
antitumor immune response ; tumor-infiltrating lymphocytes ; immunotherapy ; triple-negative breast cancer
Sažetak
Tumor stimulates specific innate and acquired immune mechanisms. Main carriers of body’s immune response to tumor are T lymphocytes and main mechanism is killing of tumor cells by cytotoxic T lymphocytes CD8 +. In some cases, immune system can also have a protumor role, which is a paradox, given that it is known that the inflammatory state promotes tumor growth. One of the major characteristics of tumors is the evading of immune response, in particular by mechanisms of inhibition of active antitumor immune response via two major physiological inhibitory signals, CTLA-4 and PD1 / PDL1. Blockade of these checkpoints, that are T cell inhibitory mechanisms, has recently yielded best results in an immunotherapy approach to cancer treatment. Immune infiltrate in the tumor, as evidence of existence of an active intrinsic response of the organism, is heterogeneous, and composition often differs between different tumors and tumor cells, and mainly divides into two main cell lines: lymphoid and myeloid. On type of cell lines in the immune infiltrate and their activation and orientation depends the clinical response in different tumors. It is well known that immune infiltrate, especially tumorinfiltrating lymphocytes (TILs), can be predictive of response to therapy and have a prognostic role. In some solid tumors they are a good sign, while in some they signal worse prognosis. Numerous studies have evaluated role of lymphocytic infiltrate in breast cancer (BC) and, based on this knowledge, first consensus on standardization of TILs evaluation in solid tumors has been established on the BC model. Prognostic role of TILs in triple-negative breast cancer has received the most attention.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinika za tumore,
KBC "Sestre Milosrdnice"
Profili:
Ljubica Vazdar
(autor)
Robert Šeparović
(autor)
Damir Vrbanec
(autor)
Mirjana Pavlović
(autor)
Ana Tečić Vuger
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus